Solidus Biosciences Overview
- Year Founded
-
2005
- Status
-
Out of Business
- Latest Deal Type
-
Out of Business
Solidus Biosciences General Information
Description
Developer of a three-dimensional cell culture micro-array technology designed to provide the high-throughput screening of both compounds and their metabolites for toxicity. The company's technology uses a biocatalytic platform to profile chemical compound toxicity to enhance decision-making for supporting new product development in the pharmaceutical, biotechnology, cosmetics, and agrichemical industries, enabling researchers to improve the process of new drug development by getting proprietary decision-enabling technology to enhance drug safety, efficiency, cost and, thereby, productivity from investment in new drug research and development.
Contact Information
Website
www.solidusbio.comCorporate Office
- 409 Illinois Street
- Suite 2073
- San Francisco, CA 94158-2509
- United States
Corporate Office
- 409 Illinois Street
- Suite 2073
- San Francisco, CA 94158-2509
- United States
Solidus Biosciences Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 7. Out of Business | 01-Apr-2016 | Completed | Out of Business | |||
| 6. Grant | 01-Dec-2012 | Completed | Generating Revenue | |||
| 5. Grant | 01-Jan-2008 | Completed | Generating Revenue | |||
| 4. Grant | 01-Jan-2007 | Completed | Startup | |||
| 3. Grant | 26-Dec-2005 | Completed | Startup | |||
| 2. Early Stage VC | Completed | Startup | ||||
| 1. University Spin-Out | 01-Jan-2005 | Completed | Startup |
Solidus Biosciences Patents
Solidus Biosciences Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| EP-3976806-A1 | Recombinant herpesvirales vector | Inactive | 30-May-2019 | ||
| EP-3893940-A1 | Combination therapy for treating muscular dystrophy | Inactive | 12-Dec-2018 | ||
| EP-3893940-A4 | Combination therapy for treating muscular dystrophy | Inactive | 12-Dec-2018 | ||
| US-20140154722-A1 | Apparatus for analyzing biomaterial | Inactive | 12-Aug-2011 | ||
| WO-2013025542-A1 | Apparatus for analyzing biomaterial | Inactive | 12-Aug-2011 | C12M23/12 |
Solidus Biosciences FAQs
-
When was Solidus Biosciences founded?
Solidus Biosciences was founded in 2005.
-
Where is Solidus Biosciences headquartered?
Solidus Biosciences is headquartered in San Francisco, CA.
-
What industry is Solidus Biosciences in?
Solidus Biosciences’s primary industry is Biotechnology.
-
Is Solidus Biosciences a private or public company?
Solidus Biosciences is a Private company.
-
What is Solidus Biosciences’s current revenue?
The current revenue for Solidus Biosciences is .
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process